Tenofovir disoproxil ( DrugBank: Tenofovir disoproxil, Tenofovir )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
93	原発性胆汁性胆管炎	1
265	脂肪萎縮症	2

93. 原発性胆汁性胆管炎

臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03954327 (ClinicalTrials.gov)	June 29, 2020	7/5/2019	Combination Antiretroviral Therapy (cART) for PBC	Randomized Controlled Trail (RCT) of Emtricitabine, Tenofovir Disoproxiland Raltegravir for Patients ...	Primary Biliary Cholangitis	Drug: Emtricitabine (FTC)/Tenofovir Disoproxil(TDF);Drug: Raltegravir;Drug: Placebo Oral Capsule [CE ...	University of Alberta	Merck Sharp & Dohme Corp.	Recruiting	18 Years	N/A	All	60	Phase 2	Canada

臨床試験数 : 112 / 薬物数 : 155 - (DrugBank : 55) / 標的遺伝子数 : 25 - 標的パスウェイ数 : 97

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04903847 (ClinicalTrials.gov)	February 2, 2021	9/10/2020	Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Ten ...	Changes in Weight After Switch to Dolutegravir/Lamivudine or Doravirine/Tenofovir/Lamivudine Compare ...	Hiv;HIV Infections;HIV Lipodystrophy;Osteoporosis;Renal Insufficiency;Weight Gain;Obesity	Drug: Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO];Drug: Doravirine/Lamivudine/Tenofovi ...	Thomas Benfield	NULL	Recruiting	18 Years	N/A	All	126	Phase 4	Denmark
2	NCT00119379 (ClinicalTrials.gov)	April 2005	11/7/2005	Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infe ...	Reversibility of Mitochondrial Toxicity in HIV Lipoatrophy	HIV Infections;Lipodystrophy;Metabolic Diseases;Nutrition Disorders	Drug: NucleomaxX;Drug: Tenofovir Disoproxil Fumarate	National Institute of Allergy and Infectious Diseases (NIAID)	NULL	Completed	18 Years	N/A	All	50	Phase 2	United States